Cargando…
Type-I interferons in the immunopathogenesis and treatment of Coronavirus disease 2019
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is currently the major global health problem. Still, it continues to infect people globally and up to the end of February 2022, over 436 million confirmed cases of COVID-19, incl...
Autores principales: | Khorramdelazad, Hossein, Kazemi, Mohammad Hossein, Azimi, Maryam, Aghamajidi, Azin, Mehrabadi, Ali Zarezadeh, Shahba, Faezeh, Aghamohammadi, Nazanin, Falak, Reza, Faraji, Fatemeh, Jafari, Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124632/ https://www.ncbi.nlm.nih.gov/pubmed/35618037 http://dx.doi.org/10.1016/j.ejphar.2022.175051 |
Ejemplares similares
-
Age-dependent immune responses in COVID-19-mediated liver injury: focus on cytokines
por: Aghamohamadi, Nazanin, et al.
Publicado: (2023) -
B lymphocytes in COVID-19: a tale of harmony and discordance
por: Mansourabadi, Amir Hossein, et al.
Publicado: (2023) -
Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection
por: Khorramdelazad, Hossein, et al.
Publicado: (2021) -
Mesenchymal stem cells- derived exosomes inhibit the expression of Aquaporin-5 and EGFR in HCT-116 human colorectal carcinoma cell line
por: Mansourabadi, Amir Hossein, et al.
Publicado: (2022) -
Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?
por: Kazemi, Mohammad Hossein, et al.
Publicado: (2022)